BioCentury
ARTICLE | Company News

G-BA may assess pre-AMNOG cancer drugs

November 15, 2013 2:02 AM UTC

Germany's Federal Joint committee said it plans to assess cancer drugs that were marketed before drug pricing law AMNOG came into effect. The announcement is likely a formality because of this month's...